IL132808A - תולדות אריתרומיצין ואזיתרומיצין המותמרות בפחמן בעמדה " 4, הכנתן ותכשירי רוקחות המכילים אותן - Google Patents

תולדות אריתרומיצין ואזיתרומיצין המותמרות בפחמן בעמדה " 4, הכנתן ותכשירי רוקחות המכילים אותן

Info

Publication number
IL132808A
IL132808A IL13280898A IL13280898A IL132808A IL 132808 A IL132808 A IL 132808A IL 13280898 A IL13280898 A IL 13280898A IL 13280898 A IL13280898 A IL 13280898A IL 132808 A IL132808 A IL 132808A
Authority
IL
Israel
Prior art keywords
compound
formula
membered
optionally substituted
groups
Prior art date
Application number
IL13280898A
Other languages
English (en)
Other versions
IL132808A0 (en
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Priority to IL15733698A priority Critical patent/IL157336A0/xx
Priority to IL15733798A priority patent/IL157337A0/xx
Publication of IL132808A0 publication Critical patent/IL132808A0/xx
Publication of IL132808A publication Critical patent/IL132808A/he

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL13280898A 1997-06-11 1998-05-25 תולדות אריתרומיצין ואזיתרומיצין המותמרות בפחמן בעמדה " 4, הכנתן ותכשירי רוקחות המכילים אותן IL132808A (he)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL15733698A IL157336A0 (en) 1997-06-11 1998-05-25 Intermediates in the preparation of c-4"-substituted erythromycin and azithromycin derivatives
IL15733798A IL157337A0 (en) 1997-06-11 1998-05-25 Intermediates in the preparation of c-4"-substituted erythromycin and azithromycin derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4998097P 1997-06-11 1997-06-11
PCT/IB1998/000799 WO1998056801A1 (en) 1997-06-11 1998-05-25 C-4''-substituted macrolide derivatives

Publications (2)

Publication Number Publication Date
IL132808A0 IL132808A0 (en) 2001-03-19
IL132808A true IL132808A (he) 2004-08-31

Family

ID=21962765

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13280898A IL132808A (he) 1997-06-11 1998-05-25 תולדות אריתרומיצין ואזיתרומיצין המותמרות בפחמן בעמדה " 4, הכנתן ותכשירי רוקחות המכילים אותן

Country Status (40)

Country Link
EP (1) EP0988309B1 (he)
JP (1) JP3262806B2 (he)
KR (1) KR100369959B1 (he)
CN (1) CN1145636C (he)
AP (1) AP1189A (he)
AR (1) AR013085A1 (he)
AT (1) ATE310742T1 (he)
AU (1) AU745006C (he)
BG (1) BG64357B1 (he)
BR (1) BR9810097A (he)
CA (1) CA2293397C (he)
CO (1) CO4950584A1 (he)
DE (1) DE69832486T2 (he)
DZ (1) DZ2515A1 (he)
EA (1) EA002440B1 (he)
ES (1) ES2251081T3 (he)
GT (1) GT199800075A (he)
HK (1) HK1025974A1 (he)
HN (1) HN1998000074A (he)
HR (1) HRP980315A2 (he)
HU (1) HUP0004076A3 (he)
ID (1) ID24530A (he)
IL (1) IL132808A (he)
IS (1) IS1979B (he)
MA (1) MA24563A1 (he)
MY (1) MY133027A (he)
NO (1) NO315560B1 (he)
NZ (1) NZ500652A (he)
OA (1) OA11226A (he)
PA (1) PA8452001A1 (he)
PE (1) PE79999A1 (he)
PL (1) PL337497A1 (he)
SK (1) SK168299A3 (he)
TN (1) TNSN98084A1 (he)
TW (2) TW200418871A (he)
UA (1) UA70298C2 (he)
UY (1) UY25041A1 (he)
WO (1) WO1998056801A1 (he)
YU (1) YU62999A (he)
ZA (1) ZA985016B (he)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1779853A3 (en) * 1997-09-10 2010-01-27 Merial Ltd. 9a-azalides as veterinary antimicrobial agents
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
WO1999012552A1 (en) * 1997-09-10 1999-03-18 Merck & Co., Inc. 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
EP1437360A3 (en) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11 Carbamates of macrolide antibacterials
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
OA11670A (en) 1998-11-03 2005-01-12 Pfizer Prod Inc Novel macrolide antibiotics.
CA2411293A1 (en) * 1999-01-28 2000-07-28 Pfizer Products Inc. Novel azalides and methods of making same
US6764996B1 (en) 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
DE60025370T2 (de) * 1999-08-24 2006-09-21 Abbott Laboratories, Abbott Park 9a-azalide mit antibakterieller wirkung
PT1250343E (pt) * 2000-01-27 2003-11-28 Pfizer Prod Inc Composicoes de antibioticos de azalida
BR0209241A (pt) * 2001-04-27 2004-06-15 Pfizer Prod Inc Processo para preparação de derivados de9-deoxo-9a-aza-9a-homoeritromicina a 4-substituida
JP2003040782A (ja) * 2001-05-31 2003-02-13 Pfizer Prod Inc アザリド抗生物質組成物
JP2005536488A (ja) * 2002-07-08 2005-12-02 プリヴァ−イストラジヴァキ・インスティトゥ・ディー・オー・オー 新規な非ステロイド抗炎症物質、組成物、およびその使用方法
RU2330858C2 (ru) 2002-07-08 2008-08-10 Глаксомитклайн Истраживацки Центар Загреб Д.О.О. Новые соединения, составы и способы лечения воспалительных заболеваний и состояний
RS20050006A (en) 2002-07-08 2007-09-21 Glaxo Smith Kline Istraživački Centar Zagreb D.O.O., Novel compounds,compositions as carriers for steroid/non- steroid anti-inflammatory,antineoplastic and antiviral active molecules
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
CA2529817C (en) * 2003-03-10 2013-02-12 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
US7276487B2 (en) 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
US8202843B2 (en) 2004-02-27 2012-06-19 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
US8293715B2 (en) 2007-08-06 2012-10-23 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound crosslinked at 10a- and 12-positions
JP5698979B2 (ja) 2007-10-25 2015-04-08 センプラ ファーマシューティカルズ，インコーポレイテッド マクロライド系抗菌剤の調製プロセス
JPWO2009139181A1 (ja) 2008-05-15 2011-09-15 大正製薬株式会社 ４員環構造を有する１０ａ−アザライド化合物
JP5602748B2 (ja) 2008-10-24 2014-10-08 センプラ ファーマシューティカルズ，インコーポレイテッド トリアゾール含有マクロライドを用いた生体防御
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2532455T3 (es) * 2010-09-20 2015-03-27 Novartis Tiergesundheit Ag Nuevo procedimiento de preparación de 9-desoxo-9a-aza-9a-homoeritromicina modificada en el C-4'' del anillo de cladinosa por un grupo epóxido
AR085286A1 (es) * 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4
US10188674B2 (en) 2012-03-27 2019-01-29 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
JP5857008B2 (ja) * 2012-08-20 2016-02-10 大正製薬株式会社 Ｃ−４”位置換マクロライド誘導体を含有する医薬
KR102528984B1 (ko) * 2013-04-04 2023-05-08 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 매크롤라이드 그리고 그의 제조방법 및 용도
CN103965273B (zh) * 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN105669798B (zh) * 2013-08-23 2019-07-26 普莱柯生物工程股份有限公司 一种大环内酯类化合物
AR102810A1 (es) 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd Derivado de macrólido sustituido en la posición c-4
JP2017531663A (ja) 2014-10-08 2017-10-26 プレジデント アンド フェローズ オブ ハーバード カレッジ １４員ケトライドならびにそれらの調製および使用の方法
WO2016154591A1 (en) 2015-03-25 2016-09-29 President And Fellows Of Harvard College Macrolides with modified desosamine sugars and uses thereof
CN108003207B (zh) 2017-12-19 2019-05-10 海门慧聚药业有限公司 制备泰拉霉素的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE445223B (sv) * 1977-02-04 1986-06-09 Pfizer Sett att framstella 4"-amino-erytomylin-a-derivat
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
EP0136831B1 (en) * 1983-09-06 1988-11-09 Pfizer Inc. Azahomoerythromycin b derivatives and intermediates thereof
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US5412982A (en) * 1994-03-10 1995-05-09 Potts; James K. Windsock support

Also Published As

Publication number Publication date
CA2293397A1 (en) 1998-12-17
NO996107D0 (no) 1999-12-10
TWI224106B (en) 2004-11-21
IS1979B (is) 2005-01-14
KR20010013633A (ko) 2001-02-26
EP0988309B1 (en) 2005-11-23
ZA985016B (en) 1999-12-10
NO315560B1 (no) 2003-09-22
AU7228198A (en) 1998-12-30
EA199901014A1 (ru) 2000-06-26
EP0988309A1 (en) 2000-03-29
UA70298A (uk) 2004-10-15
SK168299A3 (en) 2000-09-12
DE69832486T2 (de) 2006-07-27
TNSN98084A1 (fr) 2005-03-15
ID24530A (id) 2000-07-20
NO996107L (no) 2000-02-10
NZ500652A (en) 2001-10-26
ES2251081T3 (es) 2006-04-16
WO1998056801A1 (en) 1998-12-17
AP1189A (en) 2003-07-16
CN1259955A (zh) 2000-07-12
PA8452001A1 (es) 2000-05-24
AP9801254A0 (en) 1998-06-30
BG103969A (en) 2000-07-31
JP2000514097A (ja) 2000-10-24
AU745006C (en) 2006-02-23
AR013085A1 (es) 2000-12-13
DE69832486D1 (de) 2005-12-29
MA24563A1 (fr) 1998-12-31
IL132808A0 (en) 2001-03-19
KR100369959B1 (ko) 2003-02-12
JP3262806B2 (ja) 2002-03-04
IS5250A (is) 1999-11-16
AU745006B2 (en) 2002-03-07
HUP0004076A3 (en) 2003-05-28
OA11226A (en) 2003-07-16
CA2293397C (en) 2004-08-31
UY25041A1 (es) 2000-09-29
GT199800075A (es) 1999-11-30
HK1025974A1 (en) 2000-12-01
YU62999A (sh) 2002-10-18
DZ2515A1 (fr) 2003-02-01
UA70298C2 (uk) 2004-10-15
ATE310742T1 (de) 2005-12-15
MY133027A (en) 2007-10-31
HUP0004076A2 (hu) 2001-04-28
CO4950584A1 (es) 2000-09-01
EA002440B1 (ru) 2002-04-25
BG64357B1 (bg) 2004-11-30
BR9810097A (pt) 2000-08-08
PE79999A1 (es) 1999-08-25
TW200418871A (en) 2004-10-01
HN1998000074A (es) 1999-01-08
HRP980315A2 (en) 1999-04-30
CN1145636C (zh) 2004-04-14
PL337497A1 (en) 2000-08-28

Similar Documents

Publication Publication Date Title
US6420536B1 (en) 4″-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
EP0988309B1 (en) C-4''-substituted macrolide derivatives
US6576749B2 (en) C-4″-substituted macrolide derivatives
EP0984019B1 (en) C11 carbamates of macrolide antibacterials
IL142631A (en) 13-membered azalides, their preparation and pharmaceutical compositions containing them
MXPA99011496A (en) C-4''-substituted macrolide derivatives
CZ438999A3 (cs) C-4"- substituované makrolidové deriváty
MXPA99011495A (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
EP1437360A2 (en) C11 Carbamates of macrolide antibacterials

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees